Boston Scientific Corp (BSX) 23.70 $BSX
Global Vascular Stents Market 2016-2020 With Abbott Laboratories, Boston Scientific, Cook Medical, Cordis, Medtronic & W.L. Gore & Associates Dominating - Research and Markets
BusinessWire - Tue Jul 12, 4:15AM CDT
Research and Markets has announced the addition of the "Global Vascular Stents Market 2016-2020" report to their offering.
BSX: 23.70 (-0.07), MDT: 89.15 (+0.64)
China Cardiac Rhythm Management Devices Market 2016-2020 - Key Vendors are BIOTRONIK, Boston Scientific, LivaNova & Medtronic - Research and Markets
BusinessWire - Mon Jul 11, 10:08AM CDT
Research and Markets has announced the addition of the "Cardiac Rhythm Management Devices Market in China 2016-2020" report to their offering.
BSX: 23.70 (-0.07), MDT: 89.15 (+0.64)
Henry Schein Rides High on Strategic Buyouts, Price Hurts
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:58AM CDT
Henry Schein's (HSIC) latest acquisition development includes the completion of its takeover of 50% interest in J Morita's subsidiary, One Piece Corp.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), HSIC: 181.32 (-0.46), NUVA: 61.12 (-0.45)
Global Cardiac Resynchronization Therapy Defibrillator Market Growth of 8.36% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Boston Scientific, Medtronic, BIOTRONIK - Research and Markets
BusinessWire - Wed Jul 06, 10:13AM CDT
Research and Markets has announced the addition of the "Global Cardiac Resynchronization Therapy Defibrillator Market 2016-2020" report to their offering.
BSX: 23.70 (-0.07), MDT: 89.15 (+0.64)
Cooper Companies Strong on Portfolio Expansion Plans
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:38AM CDT
The Cooper Companies Inc. (COO) is firing on all cylinders, buoyed by its expanding product portfolio and consistent earnings results.
BSX: 23.70 (-0.07), JNJ: 122.79 (-0.14), BEAT: 17.65 (+0.15), COO: 179.95 (-2.15)
Zimmer Biomet Poised on LDR Inclusion, Product Launches
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:12AM CDT
On Jul 4, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), ZBH: 125.84 (+0.76), NUVA: 61.10 (-0.47)
Shares of BSX Up 29.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jul 05, 1:09PM CDT
SmarTrend identified an Uptrend for Boston Scientific (NYSE:BSX) on March 14th, 2016 at $18.01. In approximately 4 months, Boston Scientific has returned 29.58% as of today's recent price of $23.33.
BSX: 23.70 (-0.07)
FDA approves first dissolving stent for US patients
By MATTHEW PERRONE - AP - Tue Jul 05, 4:30PM CDT
WASHINGTON (AP) — A medical implant that slowly dissolves into the body could be the answer to long-standing safety concerns with devices used to treat clogged arteries.
BSX: 23.70 (-0.07), ABT: 42.36 (+0.24), MDT: 89.15 (+0.64)
Abaxis: Growth on Test Menu Expansion; Competition Rife
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 10:38AM CDT
Abaxis (ABAX) has been working on expanding its portfolio of rapid test menu over the recent past.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), ABAX: 52.35 (+0.35), NUVA: 61.10 (-0.47)
NuVasive (NUVA) at 52-Week High on Strategic Initiatives
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 8:03AM CDT
Currently, NuVasive (NUVA) expects its international business to grow by 38% in 2016, at CER.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), GWPH: 96.81 (+0.46), NUVA: 61.10 (-0.47)
Akers Biosciences Chlamydia Rapid Test Results Positive
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 8:33AM CDT
Shares of Akers Biosciences Inc. (AKER) surged 15.8% to close at $3.22 following the completion of a clinical trial on the company's Chlamydia rapid test.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), CAH: 81.89 (+0.83), AKER: 2.90 (+0.10)
Myriad Genetics: Study Data Drives Growth, Competition Rife
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 7:51AM CDT
Most recent study data from the Nova trial shows Myriad's (MYGN) myChoice HRD test's effectiveness in detecting an increased number of ovarian cancer patients
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), MYGN: 32.21 (+0.15), LMAT: 13.91 (+0.27)
GNC Holdings' Overseas Prospects Robust Amid Market Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 4:35PM CDT
On Jun 30, 2016, we issued an updated research report on Pittsburgh, PA-based GNC Holdings, Inc. (GNC).
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), GNC: 26.17 (+0.42), STJ: 80.87 (+0.20)
Medtronic (MDT) Focuses on Cardiac Management Portfolio
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 9:00AM CDT
Following the release, shares of Medtronic gained 1.56% to reach $85.45 at the end of yesterday's trading session.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), MDT: 89.15 (+0.64), STJ: 80.87 (+0.20)
Research Report Initiated on Select Medical Appliances & Equipment Equities
ACCESSWIRE - Thu Jun 30, 8:15AM CDT
LONDON, UK / ACCESSWIRE / June 30, 2016 / Active Wall St announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Medical Appliances & Equipment industry. Companies recently under review include Boston Scientific, Abbott Laboratories, Medtronic, and Hologic. See our complete report on Boston Scientific at:
BSX: 23.70 (-0.07), ABT: 42.36 (+0.24), MDT: 89.15 (+0.64), HOLX: 35.73 (+0.12)
CR Bard (BCR) at 52-Week High on Strong Product Pipeline
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 7:27AM CDT
Shares of CR Bard (BCR) rallied to a new 52-week high of $232.77 on Jun 29.
HYH: 34.65 (+0.39), BSX: 23.70 (-0.07), BCR: 236.65 (-0.52), CNMD: 49.82 (+0.49)
Baxter International: Health Canada Okays AMIA APD System
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 7:27AM CDT
Baxter International Inc. (BAX) is forging ahead with its expansion plans in Canada with the launch of AMIA Automated Peritoneal Dialysis (APD) System.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), BAX: 46.88 (+0.39), NUVA: 61.10 (-0.47)
Boston Scientific Set to Possibly Pullback After Yesterday's Rally of 3.04%
Comtex SmarTrend(R) - Wed Jun 29, 2:50PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $22.55 to a high of $23.03. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $22.95 on volume of 4.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BSX: 23.70 (-0.07)
Look for Shares of Boston Scientific to Potentially Pullback after Yesterday's 3.04% Rise
Comtex SmarTrend(R) - Wed Jun 29, 2:49PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $22.55 to a high of $23.03. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $22.95 on volume of 4.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BSX: 23.70 (-0.07)
Illumina, MolecularMD to Co-Develop Oncology Diagnostics
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:07AM CDT
The collaboration will combine Illumina's (ILMN) expertise in NGS technology with MolecularMD's experience in developing molecular testing for new oncology drugs
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), LMAT: 13.91 (+0.27), ILMN: 146.28 (+6.64)
Global Vascular Stents Market 2016-2020 With Abbott Laboratories, Boston Scientific, Cook Medical, Cordis, Medtronic & W.L. Gore & Associates Dominating - Research and Markets
BusinessWire - Tue Jul 12, 4:15AM CDT
Research and Markets has announced the addition of the "Global Vascular Stents Market 2016-2020" report to their offering.
BSX: 23.70 (-0.07), MDT: 89.15 (+0.64)
China Cardiac Rhythm Management Devices Market 2016-2020 - Key Vendors are BIOTRONIK, Boston Scientific, LivaNova & Medtronic - Research and Markets
BusinessWire - Mon Jul 11, 10:08AM CDT
Research and Markets has announced the addition of the "Cardiac Rhythm Management Devices Market in China 2016-2020" report to their offering.
BSX: 23.70 (-0.07), MDT: 89.15 (+0.64)
Henry Schein Rides High on Strategic Buyouts, Price Hurts
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:58AM CDT
Henry Schein's (HSIC) latest acquisition development includes the completion of its takeover of 50% interest in J Morita's subsidiary, One Piece Corp.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), HSIC: 181.32 (-0.46), NUVA: 61.12 (-0.45)
Global Cardiac Resynchronization Therapy Defibrillator Market Growth of 8.36% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Boston Scientific, Medtronic, BIOTRONIK - Research and Markets
BusinessWire - Wed Jul 06, 10:13AM CDT
Research and Markets has announced the addition of the "Global Cardiac Resynchronization Therapy Defibrillator Market 2016-2020" report to their offering.
BSX: 23.70 (-0.07), MDT: 89.15 (+0.64)
Cooper Companies Strong on Portfolio Expansion Plans
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:38AM CDT
The Cooper Companies Inc. (COO) is firing on all cylinders, buoyed by its expanding product portfolio and consistent earnings results.
BSX: 23.70 (-0.07), JNJ: 122.79 (-0.14), BEAT: 17.65 (+0.15), COO: 179.95 (-2.15)
Zimmer Biomet Poised on LDR Inclusion, Product Launches
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:12AM CDT
On Jul 4, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), ZBH: 125.84 (+0.76), NUVA: 61.10 (-0.47)
Shares of BSX Up 29.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jul 05, 1:09PM CDT
SmarTrend identified an Uptrend for Boston Scientific (NYSE:BSX) on March 14th, 2016 at $18.01. In approximately 4 months, Boston Scientific has returned 29.58% as of today's recent price of $23.33.
BSX: 23.70 (-0.07)
FDA approves first dissolving stent for US patients
By MATTHEW PERRONE - AP - Tue Jul 05, 4:30PM CDT
WASHINGTON (AP) — A medical implant that slowly dissolves into the body could be the answer to long-standing safety concerns with devices used to treat clogged arteries.
BSX: 23.70 (-0.07), ABT: 42.36 (+0.24), MDT: 89.15 (+0.64)
Abaxis: Growth on Test Menu Expansion; Competition Rife
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 10:38AM CDT
Abaxis (ABAX) has been working on expanding its portfolio of rapid test menu over the recent past.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), ABAX: 52.35 (+0.35), NUVA: 61.10 (-0.47)
NuVasive (NUVA) at 52-Week High on Strategic Initiatives
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 8:03AM CDT
Currently, NuVasive (NUVA) expects its international business to grow by 38% in 2016, at CER.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), GWPH: 96.81 (+0.46), NUVA: 61.10 (-0.47)
Akers Biosciences Chlamydia Rapid Test Results Positive
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 8:33AM CDT
Shares of Akers Biosciences Inc. (AKER) surged 15.8% to close at $3.22 following the completion of a clinical trial on the company's Chlamydia rapid test.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), CAH: 81.89 (+0.83), AKER: 2.90 (+0.10)
Myriad Genetics: Study Data Drives Growth, Competition Rife
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 7:51AM CDT
Most recent study data from the Nova trial shows Myriad's (MYGN) myChoice HRD test's effectiveness in detecting an increased number of ovarian cancer patients
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), MYGN: 32.21 (+0.15), LMAT: 13.91 (+0.27)
GNC Holdings' Overseas Prospects Robust Amid Market Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 4:35PM CDT
On Jun 30, 2016, we issued an updated research report on Pittsburgh, PA-based GNC Holdings, Inc. (GNC).
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), GNC: 26.17 (+0.42), STJ: 80.87 (+0.20)
Medtronic (MDT) Focuses on Cardiac Management Portfolio
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 9:00AM CDT
Following the release, shares of Medtronic gained 1.56% to reach $85.45 at the end of yesterday's trading session.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), MDT: 89.15 (+0.64), STJ: 80.87 (+0.20)
Research Report Initiated on Select Medical Appliances & Equipment Equities
ACCESSWIRE - Thu Jun 30, 8:15AM CDT
LONDON, UK / ACCESSWIRE / June 30, 2016 / Active Wall St announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Medical Appliances & Equipment industry. Companies recently under review include Boston Scientific, Abbott Laboratories, Medtronic, and Hologic. See our complete report on Boston Scientific at:
BSX: 23.70 (-0.07), ABT: 42.36 (+0.24), MDT: 89.15 (+0.64), HOLX: 35.73 (+0.12)
CR Bard (BCR) at 52-Week High on Strong Product Pipeline
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 7:27AM CDT
Shares of CR Bard (BCR) rallied to a new 52-week high of $232.77 on Jun 29.
HYH: 34.65 (+0.39), BSX: 23.70 (-0.07), BCR: 236.65 (-0.52), CNMD: 49.82 (+0.49)
Baxter International: Health Canada Okays AMIA APD System
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 7:27AM CDT
Baxter International Inc. (BAX) is forging ahead with its expansion plans in Canada with the launch of AMIA Automated Peritoneal Dialysis (APD) System.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), BAX: 46.88 (+0.39), NUVA: 61.10 (-0.47)
Boston Scientific Set to Possibly Pullback After Yesterday's Rally of 3.04%
Comtex SmarTrend(R) - Wed Jun 29, 2:50PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $22.55 to a high of $23.03. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $22.95 on volume of 4.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BSX: 23.70 (-0.07)
Look for Shares of Boston Scientific to Potentially Pullback after Yesterday's 3.04% Rise
Comtex SmarTrend(R) - Wed Jun 29, 2:49PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $22.55 to a high of $23.03. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $22.95 on volume of 4.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BSX: 23.70 (-0.07)
Illumina, MolecularMD to Co-Develop Oncology Diagnostics
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:07AM CDT
The collaboration will combine Illumina's (ILMN) expertise in NGS technology with MolecularMD's experience in developing molecular testing for new oncology drugs
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), LMAT: 13.91 (+0.27), ILMN: 146.28 (+6.64)
